PuSH - Publikationsserver des Helmholtz Zentrums München

Aguirre Bueno, J. ; Gasteiger, C. ; Hindelang, B. ; Seeger, M. ; Berezhnoi, A. ; Weidenfeld, I. ; Darsow, U.* ; Stiel, A.-C. ; Steimle-Grauer, S.A.* ; Posch, C.* ; Biedermann, T.* ; Ntziachristos, V.

Non-invasive characterization of melanoma depth at single-cell resolution.

J. Eur. Acad. Dermatol. Venereol., DOI: 10.1111/jdv.20811 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Efficient staging and management of cutaneous melanoma, one of today's deadliest skin cancers, requires non-invasive determination of tumour depth (Breslow depth). However, current imaging technologies lack the necessary contrast or penetration to measure Breslow depth. OBJECTIVES: To determine if raster-scanning optoacoustic mesoscopy (RSOM) can fill this gap in dermatology. METHODS: We used phantoms to optimize RSOM for melanoma imaging and demonstrated its capability to image melanocytes at single-cell resolution in deep tissue. We then compared RSOM's ability to measure Breslow depth against the clinical standard in a pilot study. For the phantoms studies, we compared the ability of an optimized RSOM system to measure the concentration and diameter of single melanoma cells against gold-standard microscopy methods. For the pilot clinical study, we used linear regression to compare RSOM's Breslow depth against the clinical standard, obtaining the goodness of fit (R2) and the p-value. For the pilot clinical study, we imaged nine lesions: 7 superficially spreading melanomas, 1 benign dysplastic nevus and 1 blue nevus. The average age of the patients was 56.2 ± 12.5 years. We also imaged 10 non-lesional skin areas from healthy volunteers. RESULTS: By utilizing ultra-wideband frequency detection and optimized illumination wavelength, we show that RSOM achieves non-invasive imaging of melanoma at the resolution of single melanocytes, penetrating more than 3 mm into the skin. The agreement between RSOM and the standard-of-care histological assessment was R2 = 0.886 (p = 0.0002) for Breslow depth determination. CONCLUSIONS: RSOM provides non-invasive imaging performance that correlates with the Breslow depth determination. Further work is needed to confirm these findings and to test RSOM against other non-invasive methods.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cells ; Imaging ; Melanoma ; Melanoma Classification; Reflectance Confocal Microscopy; High-frequency Ultrasound; Malignant-melanoma; Cutaneous Melanoma; Thickness
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0926-9959
e-ISSN 1468-3083
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-505500-001
G-505591-004
Förderungen HORIZON EUROPE European Innovation Council
Scopus ID 105009839623
PubMed ID 40607870
Erfassungsdatum 2025-07-16